Testing effectiveness (Phase 2)Study completedNCT01010672
What this trial is testing
Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)
Who this might be right for
Sarcoma
Merck Sharp & Dohme LLC 50